TipRanks
Go Ultimate55% OFF

Anavex Life Sciences (12X1) Income Statement

Anavex Life Sciences Income Statement

Last quarter (Q3 2026), Anavex Life Sciences's total revenue was $0.00. In Q3, Anavex Life Sciences's net income was $-3.19M. See Anavex Life Sciences’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementSep 25Sep 24Sep 23Sep 22Sep 21
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
$ 51.41M$ 52.88M$ 55.76M$ 50.99M$ 42.00M
Depreciation and Amortization$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
$ -46.38M$ -43.00M$ -46.54M$ -47.62M$ -37.64M
$ -51.41M$ -52.88M$ -55.76M$ -50.99M$ -42.00M
$ 5.03M$ 9.88M$ 8.26M$ 3.37M$ 4.36M
$ -46.38M$ -43.00M$ -47.51M$ -47.62M$ -37.64M
$ -46.38M$ -43.00M$ -47.51M$ -47.98M$ -37.91M
Per Share Metrics
Basic EPS$ -0.54$ -0.52$ -0.60$ -0.62$ -0.54
Diluted EPS$ -0.54$ -0.52$ -0.60$ -0.62$ -0.54
Weighted Average Shares Outstanding85.29M83.47M79.79M76.91M69.80M
Weighted Average Shares Outstanding (Diluted)85.29M83.47M79.79M76.91M69.80M

Currency in USD

Anavex Life Sciences Earnings and Revenue History

-60M-40M-20M00 %0.4 %0.8 %1.2 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin